S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
Log in
NYSE:MDC

M.D.C. Stock Forecast, Price & News

$57.08
+0.51 (+0.90 %)
(As of 03/1/2021 12:00 AM ET)
Add
Compare
Today's Range
$56.56
Now: $57.08
$57.82
50-Day Range
$47.13
MA: $54.86
$61.05
52-Week Range
$15.75
Now: $57.08
$61.45
Volume572,819 shs
Average Volume612,330 shs
Market Capitalization$3.70 billion
P/E Ratio11.94
Dividend Yield2.83%
Beta1.53
M.D.C. Holdings, Inc., through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name. The company conducts its homebuilding operations in Arizona, California, Nevada, Washington, Oregon, Colorado, Utah, Virginia, Maryland, and Florida. Its financial services operations comprise originating mortgage loans primarily for homebuyers; providing insurance coverage primarily to its homebuilding subsidiaries and subcontractors for homes sold by its homebuilding subsidiaries, and for work performed in completed subdivisions; acting as a re-insurer on the claims; selling third-party personal property and casualty insurance products to homebuyers; and offering title agency services to homebuilding subsidiaries and customers in Colorado, Florida, Maryland, Nevada, and Virginia. The company was founded in 1972 and is headquartered in Denver, Colorado.
M.D.C. logo

Industry, Sector and Symbol

Industry Operative builders
Sub-IndustryHomebuilding
CUSIP55267610
Phone303-773-1100
Employees1,656
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.29 billion
Cash Flow$5.06 per share
Book Value$28.49 per share

Profitability

Net Income$238.31 million

Miscellaneous

Market Cap$3.70 billion
Next Earnings Date5/4/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

2.37 out of 5 stars

Construction Sector

9th out of 205 stocks

Operative Builders Industry

5th out of 19 stocks

Analyst Opinion: 1.3Community Rank: 2.0Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 4.4 5 -4 -3 -2 -1 -
$57.08
+0.51 (+0.90 %)
(As of 03/1/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MDC News and Ratings via Email

Sign-up to receive the latest news and ratings for MDC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











M.D.C. (NYSE:MDC) Frequently Asked Questions

Is M.D.C. a buy right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for M.D.C. in the last year. There are currently 4 hold ratings, 2 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" M.D.C. stock.
View analyst ratings for M.D.C.
or view top-rated stocks.

What stocks does MarketBeat like better than M.D.C.?

Wall Street analysts have given M.D.C. a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but M.D.C. wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is M.D.C.'s next earnings date?

M.D.C. is scheduled to release its next quarterly earnings announcement on Tuesday, May 4th 2021.
View our earnings forecast for M.D.C.
.

How were M.D.C.'s earnings last quarter?

M.D.C. Holdings, Inc. (NYSE:MDC) issued its quarterly earnings data on Tuesday, February, 2nd. The construction company reported $2.19 EPS for the quarter, topping the Zacks' consensus estimate of $1.73 by $0.46. The construction company earned $1.18 billion during the quarter, compared to analysts' expectations of $1.21 billion. M.D.C. had a trailing twelve-month return on equity of 16.78% and a net margin of 8.27%. The firm's revenue was up 9.9% on a year-over-year basis. During the same period last year, the firm posted $1.42 EPS.
View M.D.C.'s earnings history
.

How has M.D.C.'s stock price been impacted by COVID-19?

M.D.C.'s stock was trading at $33.96 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MDC shares have increased by 68.1% and is now trading at $57.08.
View which stocks have been most impacted by COVID-19
.

How often does M.D.C. pay dividends? What is the dividend yield for M.D.C.?

M.D.C. announced a quarterly dividend on Thursday, January 28th. Shareholders of record on Wednesday, February 10th will be paid a dividend of $0.3429 per share on Wednesday, February 24th. This represents a $1.37 annualized dividend and a dividend yield of 2.40%. The ex-dividend date is Tuesday, February 9th.
View M.D.C.'s dividend history
.

Is M.D.C. a good dividend stock?

M.D.C. pays an annual dividend of $1.60 per share and currently has a dividend yield of 2.83%. M.D.C. does not yet have a strock track record of dividend growth. The dividend payout ratio of M.D.C. is 43.01%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, M.D.C. will have a dividend payout ratio of 24.62% next year. This indicates that M.D.C. will be able to sustain or increase its dividend.
View M.D.C.'s dividend history.

What price target have analysts set for MDC?

7 analysts have issued 1-year price targets for M.D.C.'s shares. Their forecasts range from $29.00 to $71.00. On average, they anticipate M.D.C.'s share price to reach $55.17 in the next year. This suggests that the stock has a possible downside of 3.4%.
View analysts' price targets for M.D.C.
or view top-rated stocks among Wall Street analysts.

Who are M.D.C.'s key executives?

M.D.C.'s management team includes the following people:
  • Mr. Larry A. Mizel, Exec. Chairman (Age 78, Pay $5.3M)
  • Mr. David D. Mandarich, Pres, CEO & Director (Age 73, Pay $4.84M)
  • Mr. Robert Nathaniel Martin, Sr. VP & CFO (Age 42, Pay $1.57M)
  • Mr. Michael Touff, Sr. VP (Age 76, Pay $953.35k)
  • Ms. Staci M. Woolsey, VP & Chief Accounting Officer (Age 44)
  • Mr. Ryan Berry, Director of Corp. Fin. & Assistant Treasurer
  • Mr. Kelly Taga, Chief Information Officer & VP
  • Ms. Rebecca Givens, Sr. VP & Gen. Counsel
  • Ms. Krista Montgomery, VP of HR
  • Mr. David Viger, Chief Operating Officer for Richmond American Homes

Who are some of M.D.C.'s key competitors?

What other stocks do shareholders of M.D.C. own?

Based on aggregate information from My MarketBeat watchlists, some companies that other M.D.C. investors own include Alibaba Group (BABA), Verizon Communications (VZ), The Procter & Gamble (PG), Intel (INTC), NVIDIA (NVDA), Cisco Systems (CSCO), The Home Depot (HD), Johnson & Johnson (JNJ), Pfizer (PFE) and QUALCOMM (QCOM).

What is M.D.C.'s stock symbol?

M.D.C. trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDC."

Who are M.D.C.'s major shareholders?

M.D.C.'s stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (15.40%), CVentures Inc. (12.39%), Dimensional Fund Advisors LP (7.13%), Hamlin Capital Management LLC (2.41%), Northern Trust Corp (1.55%) and Bank of New York Mellon Corp (1.36%). Company insiders that own M.D.C. stock include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald, Jean-Frederic Viret, Larry A Mizel, Leslie B Fox, Michael A Berman, Michael Touff, Paris G Reece III, Raymond T Baker, Robert Nathaniel Martin and Staci M Woolsey.
View institutional ownership trends for M.D.C.
.

Which major investors are selling M.D.C. stock?

MDC stock was sold by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Clark Capital Management Group Inc., Bank of New York Mellon Corp, Walthausen & Co. LLC, Royce & Associates LP, Heartland Advisors Inc., Squarepoint Ops LLC, and JPMorgan Chase & Co.. Company insiders that have sold M.D.C. company stock in the last year include David D Mandarich, David Siegel, Larry A Mizel, Leslie B Fox, Paris G Reece III, Robert Nathaniel Martin, and Staci M Woolsey.
View insider buying and selling activity for M.D.C.
or view top insider-selling stocks.

Which major investors are buying M.D.C. stock?

MDC stock was bought by a variety of institutional investors in the last quarter, including CVentures Inc., BlackRock Inc., Vision Capital Corp, Peregrine Capital Management LLC, Amundi Pioneer Asset Management Inc., South Street Advisors LLC, Riggs Asset Managment Co. Inc., and Healthcare of Ontario Pension Plan Trust Fund.
View insider buying and selling activity for M.D.C.
or or view top insider-buying stocks.

How do I buy shares of M.D.C.?

Shares of MDC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is M.D.C.'s stock price today?

One share of MDC stock can currently be purchased for approximately $57.08.

How much money does M.D.C. make?

M.D.C. has a market capitalization of $3.70 billion and generates $3.29 billion in revenue each year. The construction company earns $238.31 million in net income (profit) each year or $3.72 on an earnings per share basis.

How many employees does M.D.C. have?

M.D.C. employs 1,656 workers across the globe.

What is M.D.C.'s official website?

The official website for M.D.C. is www.mdcholdings.com.

Where are M.D.C.'s headquarters?

M.D.C. is headquartered at 4350 S MONACO STREET SUITE 500, DENVER CO, 80237.

How can I contact M.D.C.?

M.D.C.'s mailing address is 4350 S MONACO STREET SUITE 500, DENVER CO, 80237. The construction company can be reached via phone at 303-773-1100 or via email at [email protected]


This page was last updated on 3/2/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.